Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CTSD | P07339 | 2/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.32 |
| ▸ | RELA | Q04206 | 4/20 | 0.32 |
| ▸ | CTSV | O60911 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
| ▸ | CTSC | P53634 | 1/20 | 0.32 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.32 |
| ▸ | BTK | Q06187 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17898912 | 0.93 | GAA (0.40) | GAACTSDBACE1NFKB1NFKB2 | |
| SCHEMBL19091112 | 0.92 | GAA (0.42) | GAACTSDBACE1NFKB1NFKB2 | |
| SCHEMBL17898714 | 0.86 | KDM1A (0.36) | GAACTSDCTSLCTSSCTSK | |
| SCHEMBL19628411 | 0.85 | GAA (0.41) | GAACTSDNFKB1NFKB2RELA | |
| SCHEMBL19633453 | 0.85 | GAA (0.41) | GAACTSDBACE1 | |
| SCHEMBL19628423 | 0.84 | GAA (0.43) | GAACTSDBACE1NFKB1NFKB2 | |
| SCHEMBL17898712 | 0.84 | KDM1A (0.36) | GAACTSDCTSLCTSSCTSK | |
| SCHEMBL17426991 | 0.82 | GAA (0.43) | GAACTSDBACE1NFKB1NFKB2 | |
| SCHEMBL19628406 | 0.82 | GAA (0.39) | GAACTSDBACE1 | |
| SCHEMBL19628370 | 0.82 | KLK5 (0.43) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170334934-A1 | Macrocyclic picolinamides as fungicides | DOW AGROSCIENCES LLC (US) | 2017-11-23 | — | — | US | disclosed |
| US-20170334934-A1 | Macrocyclic picolinamides as fungicides | DOW AGROSCIENCES LLC (US) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334934-A1 | Macrocyclic picolinamides as fungicides | CYP4F12, CYP1A2, FKBP2 | GAA 1303/4885CTSD 1352/4885BACE1 2196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.